3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
5
Gastrointestinal
2
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Conditions
Malignant Solid Neoplasm
2
Stomach Neoplasms
1
Solid Tumor, Adult
1
Sarcoma
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Pelvic Neoplasms
1
Ovarian Neoplasms
1
Mesothelioma, Malignant
1
Liposarcoma
1
Fallopian Tube Neoplasms
1
Desmoplastic Small Round Cell Tumor
1
Colonic Neoplasms
1
Interventions
pembrolizumab
2
SS1(dsFv)PE38
2
Hyperthermic Intraperitoneal Chemotherapy
2
sodium thiosulfate
1
entinostat
1
X-Rays
1
Specimen Handling
1
Quality of Life
1
Polymerase Chain Reaction
1
Platinum
1
Patient Reported Outcome Measures
1
Nivolumab
1
Molecular Diagnostic Techniques
1
Microarray Analysis
1
Magnetic Resonance Spectroscopy
1
Interleukin-2
1
Immunotherapy
1
Immunoenzyme Techniques
1
Gene Expression Profiling
1
Flow Cytometry
1
Fentanyl
1
Drug Therapy
1
Doxorubicin
1
Cytoreduction Surgical Procedures
1
Cisplatin
1
Carboplatin
1
Biological Therapy
1
Bevacizumab
1
1,2-diaminocyclohexaneplatinum II citrate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
X-Rays
×
Other solid neoplasm
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled